Lung Response to Inhaled Highly Toxic Chemicals

The summary for the Lung Response to Inhaled Highly Toxic Chemicals Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.


	Federal Grant Title:	Lung Response to Inhaled Highly Toxic Chemicals
	CFDA Number:	93.838
	CFDA Description:	Lung Diseases Research
	Federal Agency Name:	National Institutes of Health
	Category of Funding Activity:	Health
	Category Explanation:	Information not provided
	Opportunity Category:	Discretionary
	Funding Opportunity Number:	PA-05-058
	Document Type:	Modification to Previous Grants Notice
	Funding Instrument Type:	Grant
	Posted Date:	May 25, 2005
	Creation Date:	Jan 09, 2007
	Original Closing Date for Applications:	Multiple Receipt Dates - See Link to Full Announcement for details.
	Current Closing Date for Applications:	Information not provided
	Archive Date:	Feb 03, 2007
	Expected Number of Awards:	Information not provided
	Estimated Total Program Funding:	Information not provided
	Federal Grant Award Ceiling:	Information not provided
	Federal Grant Award Floor:	Information not provided
	Cost Sharing or Matching Requirement:	No

Applicants Eligible for this Grant: Native American tribal organizations (other than Federally recognized tribal governments) City or township governments Native American tribal governments (Federally recognized) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled "Additional Information on Eligibility" for clarification) Special district governments County governments Public and State controlled institutions of higher education Private institutions of higher education Public housing authorities/Indian housing authorities State governments Small businesses Independent school districts For profit organizations other than small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Additional Information on Eligibility: Eligible agencies of the Federal Government are eligible to apply. Foreign institutions are eligible to apply.
Grant Description: - The primary objective of this program announcement is to encourage research about how the upper respiratory tract and lungs respond to acute exposure to highly toxic chemicals and subsequent inhalation, so that preventive strategies can be improved, antidotes devised to lessen initial irritation of mucosal surfaces, mucosal absorption minimized, and acute lung injury causing pulmonary edema counteracted. This program encourages innovative, multidisciplinary basic and clinical research of the respiratory tract with the goal of accelerating progress in the diagnosis, prevention, and treatment of toxic inhalation from chemical exposures. - The PA will use the R01 grant mechanism - Eligible organizations include: For profit or non-profit organizations, public or private institutions, such as universities, colleges, hospitals, and laboratories, units of State and local government, eligible agencies of the Federal government, domestic institutions/organizations - Eligible principal investigators include all individuals with the skills, knowledge, and resources necessary to carry out the proposed research. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH programs. - There is no limit on the number of scientifically distinct applications that may be submitted. - The PHS 398 document is available at http://grants.nih.gov/grants/funding/phs398/phs398.html in an interactive format. For further assistance contact GrantsInfo@nih.gov. Prospective applicants are urged to consult with the staff of the NHLBI early in the preparation of the application(see Section VII. Agency Contacts). - Telecommunications for the hearing impaired is available at: TTY 301-451-0088
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/pa-files/PA-05-058.html http://grants.nih.gov/grants/guide/pa-files/PA-05-058.html
Grant Announcement Contact: Webmaster, NIH, Webmaster, Phone not available, Fax not available, Email FBOWebmaster@mail.nih.gov FBOWebmaster@mail.nih.gov Webmaster, NIH
Similar Government Grants: • Short-Term Institutional Training Grant for Clinician Scientists in Pediatric Respiratory, Sleep and...; • Phase II Clinical Trials of Novel Therapies for Lung Diseases (UM1); • Development and Testing of a Case Finding Methodology in COPD (R01); • Maximizing the Scientific Value of the NHLBI Biologic Specimen Repository: Scientific Opportunities ...; • Genomic Research in AAT-Deficiency and Sarcoidosis study (GRADS) Cooperative Research Project Grant:...; • PATHOGENESIS OF SARS LUNG DISEASE: IN VITRO STUDIES AND ANIMAL MODELS; • Protein Interactions Governing Membrane Transport in Pulmonary Health and Disease (R01); • ASTHMA CLINICAL RESEARCH NETWORK; • COPD CLINICAL RESEARCH NETWORK; • NONHUMAN PRIMATE MODELS OF HIV-ASSOCIATED PULMONARY, CARDIOVASCULAR, AND HEMATOLOGICAL DISORDERS